Real-World Evidence in Patient-Reported Outcomes for Medical Cannabis (MC-RWE)

Recruiting now

Conditions studied: Pain, Sleep, Anxiety, Depression, Epilepsy

In brief

This prospective observational study aims to describe the effectiveness of MC on pain, epilepsy, sleep and /or anxiety/depression in a cohorts of patients authorized to use MC, using pre-defined, validated self assessment scales.

Key facts

Study ID

NCT04526093

Run by

University Health Network, Toronto

People needed

1000

Starts

2020-07-15

Expected to finish

2028-07-01

Last updated by the study team

2026-07-22

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects (≥19 years of age) who are MC-naïve or -experienced with a medical authorization for MC provided by a prescribing health care practitioner and who have provided informed consent
• Primary therapeutic indications for MC use: pain, epilepsy, sleep, and/or anxiety/depression.
• Subjects agree to use verified products and refrain from using any other cannabis products, either medical or recreational, during the duration of the study

You may not qualify if…

• Concomitant use of illicit drugs
• Concomitant use of recreational cannabis

Where it is running

• Toronto General Hospital, UHN — Toronto, Ontario, Canada (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.